Quantum X Labs files audited financials of acquired Quantum Israel; going concern cited

Viewbix Inc.

Quantum Israel had $0 revenue, net loss of $273k for Jan-Dec 2025; total assets $448k, cash $260k.
Auditor's report includes going-concern emphasis: losses since incorporation, negative operating cash flow.
Key asset: exclusive license from Tel Aviv University for quantum error correction technology.
Company holds equity stakes in CliniQuantum (48%), Quantum Transportation (30%), Quantum Gyro (40%).
Acquisition closed March 4, 2026; consideration includes shares and warrants representing 40% of issuer's capital plus milestone shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.